Pharmaceuticals: Merck ahead of billions of cancer specialists

The pharmaceutical company wants to strengthen its business with cancer medicines with a billion-dollar purchase. Talks with a US company are far away. With the deal, Merck would iron out its own weaknesses.

The pharmaceutical company aims to strengthen its cancer drug business with a multi-billion dollar acquisition. Talks with a US company are already well underway. The deal would allow Merck to address its own weaknesses.